SOGC/APOG Ontario CME 2017

November 30-December 2, 2017 in Toronto, Ontario

Scientific program is subject to change

Cliquez ici pour le programme en français.

Photo of Marc  Steben

Biography

Dr. Marc Steben MD

Candiac QC
Dr. Marc Steben M.D., C.C.F.P., F.C.F.P., D.E.S.S.

A family practitioner, Dr Steben is medical advisor at the STI unit of Quebec’s National Public Health Institute. He chairs Québec province committee on STI and is a member of the STI laboratory analysis committee. He is a professor, the Social and Preventive Medicine department of the School of public health at Université de Montréal. He is the medical director of Clinique A, a clinic devoted to multidisciplinary approach to sexual health.

He is a member of the Canadian STI guidelines expert group. He has chaired the 26th International papillomavirus society meeting as well as the first Public health workshop and Clinical workshop in July 2010. He is Chair of the Canadian network on HPV prevention International Centre for Infectious Diseases. He is on the board of the International Society for the Study of Vulvo-vaginal Disease, International papillomavirus society and American STD association. He is a founding member of IUSTI Canada branch of IUSTI North America.

Disclosure

I have/had an affiliation (financial or otherwise) with a pharmaceutical, medical device or communications organization.

- I am a member of an Advisory Board or equivalent with a commercial organization: Inovio, Genocea, Merck, Allergan

- I am a member of a Speaker Bureau: Merck

- I have received payment from a commercial organization (including gifts or other consideration or ‘in kind’ compensation), grant(s) or an honorarium from a commercial organization: Actavis/Allergan, Bayer, Beckton-Dickinson, Cepheid, Genocea, 3M/Graceway pharma/Medicis/Valeant, Hologic/Gen-Probe, Inovio, Merck/Merck Sharp Dohme, Sanofi-Pasteur, Roche molecular systems, Triton/Paladin/Neo

- I hold investments in a pharmaceutical organization, medical devices company or communications firms: Owner of Communications Action-Santé inc.; Mutual funds contain pharmaceutical organizations

I do intend to make therapeutic recommendations for medications that have not received regulatory approval (i.e. “off-label” use of medication).